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Background and Objective: intimal hyperplasia (IH) and constrictive remodelling are important causes of restenosis
following endovascular interventions, such as percutaneous transluminal angioplasty. Photodynamic therapy (PDT) with
5-aminolaevulinic (ALA) may prevent restenosis by cellular depletion and the elimination of cholinergic innervation.
Study design/Materials and Methods: rats (n 90) were subdivided into 4 main groups. In the experimental group
(n 36: 3 replications6 4 doses6 3 examination time-points), ALA was administered (200 mg/kg i.v.) 2±3 h before
balloon injury (BI) of the common iliac artery followed by endovascular illumination with 633 nm at either 12.5, 25, 50
or 100 J/cm diffuser length (dl BIPDT group). As control groups served the BI Light only (LO) group (n 36) that
received no ALA, the BI only group (n 9) (BI), and a group (n 9) that received a Sham procedure (Sham group).
Results: planimetric analysis showed IH of 0.28+ 0.12 mm2 (BI), 0.27+ 0.12 mm2 (BI LO at 100 J/cm dl) in contrast to
0.02+ 0.02 mm2 after BIPDT at 100 J/cm dl at 16 weeks (p5 0.05). In the BIPDT groups, a light-dose increase of a
factor 2 led to an IH decrease of 17% (p5 0.05). In the BI and BI LO groups constrictive remodelling was found, in
contrast to BIPDT treated groups at 16 weeks. The staining of cholinergic innervation of the tunic media of the blood
vessel wall in BIPDT showed no damage at the highest fluence.
Conclusion: endovascular ALA-PDT prevents IH and constrictive remodelling after BI without damage of cholinergic
innervation of the tunica media. The effective light fluence rate in the rat is 50±100 J/cm dl.
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The long-term success rate of (endo)vascular inter-
ventions to treat stenosed or occluded peripheral
arteries is determined by arterial lumen preservation,
which results in the maintenance of flow and reperfu-
sion of tissue.1 Unfortunately, the success rate is
limited by restenosis, a constriction of the artery due
to either an inadequate compensation to injury or a
progression of the arterial disease itself.2 Therefore,
re-interventions are still required in 20±40% of the
treated patients within 6 months.3
In the development of restenosis, two pathophysio-
logical determinants play a pivotal role; namelyPlease address all correspondence to: E. E. E. Gabeler MD via
Prof. Dr. H. van Urk, Department of Vascular Surgery, University
Hospital Rotterdam-Dijkzigt, Erasmus MC, Room H928,
Dr. Molewaterplein 40, 3015 GE, or POB 2040, 3000 CA, Rotterdam,
The Netherlands.
1078±5884/02/040322  10 $35.00/0 # 2002 Elsevier Science Ltd. Alintimal hyperplasia (IH)y, characterised by a fibro-
cellular hyperproliferation that obstructs the lumen,
and secondly, constrictive vascular remodelling
(CVR).4
The initiation of restenosis occurs when the clotting
cascade is activated after endothelial denudation,
fibronectin exposure and over-stretching of the tunica
media. Thrombogenicity is increased and smooth
muscle cells (SMC) proliferate and migrate from the
tunica media into the intima. With time, IH develops
and the ultrastructure of the extracellular matrix
reorganises.5CEF, circular elastic fibres between the smooth muscle cells of the
tunica media; CVR, constrictive vascular remodelling; EEL, external
elastic lamina; IEL, internal elastic lamina; IH, intimal hyperplasia;
iv, intravenous; LO, light only; MLD, maximal lumen diameter;
MWD, maximal wall diameter; PDT, photodynamic therapy; PpIX,
protoporphyrin IX; SEM, standard error of the mean; SMC, smooth
muscle cell.
l rights reserved.
Endovascular Photodynamic Therapy with Aminolaevulinic Acid 323With regard to the development of IH, a positive
correlation to the migration of SMCs from the tunica
media into the tunica intima has been described.6
Therefore, the tunica media plays a pivotal role in IH
development.
In iliac arteries, the cholinergic innervation of the
tunica intima seems to be upregulated after balloon
injury.7 A possible hypothesis is that the innervation
of the tunica media may regulate the development of
IH and the rearrangement of the extracellular ultra-
structure in peripheral arteries as well.8±15
With regard to the prevention of IH, numerous
experimental models described various degrees of
success.16±24 Brachytherapy with gamma irradiation
shows promise as a means to inhibit restenosis.25,26
At present, coated-stenting has the best long-term out-
come,27 but in-stent restenosis,28 stent-dislocation and
stent-wire failure compromises it.
Alternatively, adjuvant vascular photodynamic
therapy (PDT) may prevent restenosis by eradicating
proliferating SMCs. PDT is based on illumination of
an accumulated inert light-sensitive compound
(photosensitiser) in the SMCs of the target artery. Sub-
sequently, the use of monochromatic light activates
the photosensitiser and generates free radicals, which
eradicate the SMCs.29
In this study, the endogenous pro-drug aminolae-
vulinic acid (ALA) was used, which is a naturally
occurring intermediate in the haem biosynthetic path-
way. Then, ALA is tissue-dependently metabolised to
the photosensitiser, protoporphyrin IX (PpIX).
Experimental studies described the effectiveness of
photosensitiser-based PDT with either external or
internal illumination to prevent IH after balloon
injury (BI), but permanent focal ablation of IH without
CVR has not been accomplished.30±33 Already, clinical
studies have recently been described. A phase II
trial in the U.S.A. (Antrim-based with external illum-
ination34 and a phase III trial in the UK (ALA-
based with endoluminal illumination35) have been
initiated.Table 1. The study-design of randomised rats in the sham, balloon inj
Sham 9
Balloon injury without light 0 3




Method Fluence ÿ 
J/cm dl ALA ALA
0 weeks
PDT: photodynamic therapy; BI: balloon injury; LO: light only; ALA: 5The aim of our study was to establish the dosage-
effect relationship between light treatment and the
prevention of unfavourable arterial remodelling
using endovascular ALA-PDT in a rat model.
Materials and Methods
Rats
The experimental protocol was approved by The
Committee on Animal Research of the Erasmus Uni-
versity of Rotterdam and complied with `` Principles of
Good Laboratory Practice''. Male inbred Wistar rats
(Harlan CPB, Austerlitz, The Netherlands) weighing
200±300 g were used. The animals had free access
to rat chow (AM II, Hope Farms, Woerden, The
Netherlands) and acidified tap water, while main-
tained at a standard 12-h light/dark cycle.
Study design
Ninety rats were randomly assigned to 4 groups
(Table 1). Balloon injury (BI) was used to induce inti-
mal hyperplasia (IH) in 3 groups. In the first group
(BIPDT; n 36: 3 rats (per rat, the mean was deter-
mined using 3 heights of the damaged area) 4
doses 3 examination time-points), ALA was admin-
istered 3 h before BI, followed by endovascular illu-
mination of the occluded artery at a fluence of 12.5
(n 9), 25 (n 9), 50 (n 9) and 100 (n 9) J/cm dif-
fuser length (dl). In the second and third groups,
either light only (LO) without ALA (BILO: n 36)
or BI only (BI: n 9) was performed. The BI and
BILO groups served as references to study the
inhibitory effect of PDT on the IH development. A
fourth group underwent a Sham procedure to serve
as baseline control (Sham group: n 9). The animals
were sacrificed after either 0 h, 4 or 16 weeks for
pressure fixation of the artery (at each fluence in theury, balloon injury with light and balloon injury with PDT groups.
Sham n 9
3 3 BI n 9
3 3 3 3 BILO (ÿALA)
3 3 3 3 n 36
3 3 3 3 BIPDT (ALA)
3 3 3 3 n 36
ÿ  ÿ 
ALA ALA ALA ALA Group
4 weeks 16 weeks
-aminolaevulinic.
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324 E. E. E. Gabeler et al.group: n 3 per time-point). Cross-sections were eval-
uated using light microscopic planimetric analysis.
Photosensitisation
All groups received either i.v. 200 mg/kg ALA (Sigma±
Aldrich Chemie, Zwijndrecht, The Netherlands)
dissolved in phosphate buffered saline (PBS) at
40 mg/ml or PBS only of pH 7.45. The ALA solution
was freshly made and kept from light exposure. The
photosensitised rats were kept in the dark 2 h prior to
microsurgery, and 12 h after the operation to prevent
uncontrolled phototoxicity.
Laser
A dye laser (600 Series Dye Module, Laserscope,
Surgical Systems, San Jose, CA, U.S.A.), pumped
by a 532/KTP surgical laser (Laserscope, Surgical
Systems, San Jose, CA, U.S.A.), was used to generate
monochromatic light at 633 nm wavelength. The
power emitted from the cylindrical diffusing tip (core
diameter 200 mm, outer diameter 1.0 mm, tip length
20 mm: LightsticTM, Cardiofocus, West Yarmouth,
MA, U.S.A.)36 was calibrated with a built-in power
meter, and verified with an external linear diffuser in
an integrating cylindrical sphere (Optometer Model
370, Graseby Optronics, Orlando, FL, U.S.A.). A spec-
troscope (WaveMate, Coherent, Auburn, CA, U.S.A.)
was used to verify the accuracy of the wavelength.
Temperature
The real-time temperature during endovascular PDT
was checked at 100 mW/cm dl for 16 min and 40 s
(100 J/cm dl) to exclude high-energy induced
hyperthermal effects instead of low-energy induced
phototoxicity. Two fibre-optic thermosensors with a
diameter of 0.5 mm were coupled to a Luxtron therm-
ometry unit (Luxtron Corp., Santa Clara, CA, U.S.A.).
One was approximated parallel to the laser fibre along
the artery at an axial distance of 10 mm in the fibre tip
and the other next to the rat. The temperature was
determined every second.
Linear fluence with an isotropic probe
The linear fluence from the cylindrical diffuser in the
arterial wall was measured at an output of 100 mW/
cm dl for 16 min and 40 s (100 J/cm dl). An isotropic
probe was approximated parallel to the laser fibre
outside the artery at axial distances of 10 mm from
and 0, 10 and 20 mm in the fibre tip.Eur J Vasc Endovasc Surg Vol 24, October 2002Surgical technique
A median laparotomy was performed under general
anaesthesia with intramuscular injection of ketamine
(Ketalar, Parke Davis and Co., Inc.; 40 mg/kg) and
xylazine (Rompun Bayer Ag, Leverkusen, Germany;
5 mg/kg). The procedure was performed in subdued
light using a yellow filter (620±650 nm Kodak). The
right common iliac artery was cranially and caudally
temporarily occluded with vascular clamps. To create
a blood free lumen, the arteries were flushed with
1.0 ml heparin (50 IU/ml 0.9% NaCl) through an arter-
iotomy 5 mm cranially of the abdominal aortal bifur-
cation. Then, a balloon catheter (Fogarty arterial
embolectomy catheter, 2F, 60 cm, Baxter BV, Utrecht,
The Netherlands) was inserted and inflated with
deionised water to 2.0 bar with a manometer
(Basix25TM, Medioterm, U.S.A.).37 A right iliac artery
section of 15 mm from the bifurcation was damaged
by inflating the balloon distally of the
bifurcation. Then, after simultaneously pulling and
rotating at 120  towards the bifurcation, the balloon
was deflated at the end of the section. This procedure
was consecutively performed 3 times. A single exter-
nal suture in the vascular sheet marked the middle of
the denuded area. After flushing the lumen with hep-
arin and a two layer closing (interrupted 9-0 prolene
sutures) of the arteriotomy, both the caudal and the
cranial clamp were removed. The abdominal wall was
closed in two layers (continuous 2-0 prolene sutures).
Endovascular photodynamic therapy (PDT)
In the BILO and BIPDT group, immediately after
BI the fibre tip was centred endovascularly in the
denuded area to illuminate 15 mm of the damaged
and 2.5 mm of the untreated arterial wall both cra-
nially as well as caudally. PDT was given when the
artery was occluded (no blood flow present). Because
of the cylindrical illumination, the fluence (J) and
fluence rate (mW) was expressed per cm diffuser
length (J or mW/cm dl). An output power of
100 mW/cm dl was used in all experiments. After
treatment, the lumen was thoroughly flushed with
1 ml heparin solution (50 IU/ml). Abdominal organs
were protected from light exposure with light-
absorbing plastic during illumination. The animals
recovered in subdued light after treatment.
Specimen handling
A standard perfusion-fixation procedure via the thor-
acic aorta was performed during ether intoxication,
Endovascular Photodynamic Therapy with Aminolaevulinic Acid 325in which the lumen was flushed with PBS (pH 7.45)
for 2 min, followed by a 10-minute perfusion with
formaldehyde (3.7%) at 100 mmHg. The distally
marked segment of 20 mm was carefully harvested
after length measurement and stored in formaldehyde
(3.7%) for at least 24 h. Thereafter, the specimens were
embedded in paraffin. Three cross-sections of 10 mm
each were cut with a microtome from the distal end to
the proximal direction at 3, 5 and 10 mm from the
distal end, mounted on a slide and stained with hae-
matoxylin and eosin for conventional light micro-
scopy. All mounted sections were video-taped with a
digital camera for geometrical analysis at a magnifica-
tion of 100. A digital video analyser system (IBM
Corp., Boca Raton, U.S.A.) was used for the assessment
of the absolute intimal and medial cross-sectional
area in mm2 (Fig. 1). Intimal hyperplasia (IH) was
defined as the cross-sectional area of the cell layer
between the lumen and the internal elastic lamina.
The medial area was defined as the cross-sectional
area between the internal and external elastic lamina
(EEL). The maximal lumen diameter (MLD in mm)
and maximal wall diameter (MWD in mm) were mea-
sured to evaluate the remodelling process. Asym-
metry was corrected by using the perimeter
(D circumference/p) assuming a circular configur-
ation to calculate the MLD and MWD. The amount of
nuclei of SMCs represented the amount of SMCs per
cross-section and were counted using frame-grabber









Fig. 1. An illustration of the geometric parameters in the cross
sections. IH: Intimal Hyperplasia (mm2); Area of the tunica media
(mm2); MLD: maximal lumen diameter (mm); MWD: maximal wall
diameter (mm); MWT: maximal medial thickness (mm). IEL: inter-
nal elastic lamina; EEL: external elastic lamina. The dotted line
represents the lumen (L circ), and the black line the wall circumfer-
ence (W circ) in mm.Cholinergic unmyelinated innervation
staining of the media
Six rats from the BI (n 3) and the BIPDT at
100 J/cm dl (n 3) groups were sacrificed after 1 day
for acetylcholinesterase staining (Schwann cell stain-
ing S-100 polyclonal, Dako, KlustroÈp, Denmark) of the
frozen transverse sections from the iliac segment.38
The presence of cholinergic nerves adjacent to,
respectively, the intima, internal elastic lamina (IEL),
circular elastic fibres (CEF) in the media between the
smooth muscle cells (SMC), external elastic lamina
(EEL) and adventitia of the cross-sections were graded
using a scoring-scheme to plot the mean layer score.
The following scoring-grade was used: 0 indicated
absent staining, 1 sporadic hypodense staining (55
dots per microscopic field at a magnification of
2006) and 2 hyperdense staining (410 dots, nerve
fibre staining).
Statistical analysis
The area of intimal hyperplasia (IH), media, the maxi-
mal lumen diameter (MLD), the maximal wall diam-
eter (MWD) and the amount of SMCs were expressed
as averages of three measurements. Each of these vari-
ables was analysed separately after natural logarith-
mic transformation as dependent variable in a
multiple linear regression analysis. The independent
variables in this analysis were light dose (after log2
transformation), ALA (Y/N) and the time of sacrifi-
cing as categorical variable (weeks 4 or 16 for IH;
weeks 0, 4 or 16 for MLD and MWD). Interest is in
the regression coefficient B of light dose, expressing a
dosage-effect trend relationship. The formula
100(eBÿ1) represents the mean percentage of change
in the dependent variable as a consequence of dou-
bling the light dose. The light dose by ALA interaction
term in the regression model allows one to estimate
and test a difference in mean percentage of change
between the groups with and without ALA.
With regard to the cholinergic anti-S-100 staining,
the Spearman rank correlation coefficient between the
treatment and the staining-score was used.
Effects were considered to be significant at p-values
less than 0.05 (p5 0.05).
Results
One rat developed thrombosis within 24 h following
balloon injury in the BIPDT group (100 J/cm dl)
and was excluded from further analysis. All other
animals appeared healthy, without significant weightEur J Vasc Endovasc Surg Vol 24, October 2002
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reactions were noted in the rats exposed after ALA
injection. Omental adhesions along the abdominal
scar were seen after harvesting the iliac arteries. All
right common iliac arteries were patent at harvesting.
All sutured arteriotomies were covered with peri-
adventitial fat and an adjacent lymph node. No true
or spurial aneurysms were noted.
Temperature and applied irradiance
During the PDT procedure no hyperthermia in the
treated arterial segment was measured. The arterial
wall temperature of 32.5 0.18 C (100 J/cm dl) and
the room temperature of 19.4 1.8 C did not change.
The linear fluence in the vascular wall at the applied
irradiance matched with the output (100±110%) and
no loss or significant backscatter interference was
measured.
Histological and morphological analysis
Histology
No histological and morphological abnormalities
were found in the sham group at 0 h. Besides disrup-
tions of the internal elastic lamina caused by BI, no
signs of complete ruptures of the arterial wall were
seen microscopically in all groups. Inflammation of
the intima and media was absent at the microscopic
level in all groups.
Planimetry
The tunica intima. BIPDT statistically significantly
inhibits IH compared to the control BI and BILO
groups (p5 0.0001). If the light-dose is increased with
a factor 2 then an inhibition of 18% was obtained
compared to the control BI and BILO groups
(Fig. 2). At 16 weeks, a statistically significantly
decrease of 65.5% was obtained compared to the con-
trols (p5 0.009) (Fig. 3a,b,c).
The tunica media. BIPDT did not statistically sig-
nificantly change the area of the tunica media in
16 weeks compared to the control BI and BILO
groups (overall mean: 0.14 0.04 mm2).
Lumen and vessel wall. BIPDT statistically signifi-
cantly inhibits a decrease of the maximal lumen diam-
eter compared to the control BI and BILO groups in
16 weeks (p5 0.01) (Table 2). In general, if the light
dose increased a factor 2 in the BIPDT groups then
the maximal lumen diameter (MLD) increased statist-
ically significantly with 10% compared to the controlEur J Vasc Endovasc Surg Vol 24, October 2002BI and BILO groups (p5 0.04). At 16 weeks, a stat-
istically significant increase of 72% was found in the
BIPDT groups compared to the control BI and
BILO groups in 16 weeks. No significant difference
within the control BI and BILO groups was found.
Likewise, BIPDT statistically significantly inhibits
a decrease of the maximal wall diameter (MWD)
compared to the control BI and BILO groups in
16 weeks (p5 0.03) (Table 2). If the light dose was
increased with a factor 2 then a MWD increase of 4%
was seen (p5 0.02). While no statistically significant
difference was seen at 0 weeks, an MWD increase of
43% was seen in the BIPDT groups compared to the
BI and BILO groups in 16 weeks (p5 0.01). No
significant difference between the control BI and
BILO groups was found (p5 0.34).
Amount of SMCs in the tunica media
BIPDT significantly decreased the amount of
SMCs with 73% compared to the control BI and
BILO groups (p5 0.05) at 0 weeks (Table 3). If the
light dose increased a factor 2 then a decrease of 27%
SMCs was seen (p5 0.01). A decrease of 30% was seen
in the BIPDT groups compared to the BI and
BIBILO groups in 16 weeks (p5 0.008). The
tunica media repopulated in the BIPDT groups in
16 weeks.
Effect of PDT on the cholinergic innervation
The cholinergic innervation of the tunica media was
seen in all layers of all groups (mean 1.15 0.01). A
slight decrease of the anti-S-100 staining in the IEL
and CEF between the SMCs was seen in the BIPDT
groups compared to the control BI and BILO groups
(r: ÿ0.187; p5 0.01). However, a statistically signifi-
cant increase of the cholinergic staining was seen in
the tunica adventitia (r: 0.204; p5 0.001) of the
BIPDT group compared to the control BI and
BILO groups (Fig. 4a,b).
Discussion
In this study, the use of endovascular aminolaevulinic
acid (ALA)-based photodynamic therapy (PDT) to
prevent balloon-induced (BI) stenosis was evaluated
in a rat model. Our data show that BIPDT with
light fluences of 50 and 100 J/cm dl at the fluence
rate of 100 mW/cm dl, inhibits intimal hyperplasia
(IH) and constrictive vascular remodelling in the
medium term (16 weeks). In the BIPDT groups, a
two-fold light-dose increase led to a 17.2% decrease in
IH. However, fluences of 12.5 and 25 J/cm dl at
100 mW/cm dl were inappropriate for IH inhibition.
Fig. 2. The absolute area of intimal hyperplasia (IH) formation expressed in mm2 in the BI (--), BILO () and BIPDT (°)groups plotted
against the fluence in J/cm diffuser length at time 4 weeks (up) and 16 weeks (bottom). The dotted reference lines of the BI group are based
on the means of n 3. In all groups, no IH was seen at 0 weeks.
Endovascular Photodynamic Therapy with Aminolaevulinic Acid 327To our knowledge this is the first report that describes
the inhibition of constrictive vascular remodelling in
relation to light-dosimetry as a possible mechanism of
the PDT-induced inhibition of restenosis after BI.Both the maximal lumen diameter (MLD) and maxi-
mal wall diameter (MWD) were unchanged in the
medium term at 50 and 100 J/cm dl in the BIPDT
group, when compared to the untreated arteries. TheEur J Vasc Endovasc Surg Vol 24, October 2002
Fig. 3. Photomicrographs of HE stained cross sections of IH development in the right iliac artery at 100 magnification. The geo-
metric characteristics in relation to IH are illustrated. The scale bar represents 0.1 mm. a. BI (16 weeks). IH area reduced the maximal
lumen diameter (MLD), b. BILO 50±100 J/cm dl (16 weeks), c. BIPDT 50±100 J/cm dl (16 weeks).
Table 2. The mean maximal lumen diameter (MLD) in mm and the maximal wall diameter (MWD) of the Sham, BI, BILO and
BIPDT groups at 0, 4 and 16 weeks (wk) with n 3 per group per time-point.
Groups MLD MWD
0 wk 4 wk 16 wk 0 wk 4 wk 16 wk
Sham 0.92 0.93 1.11 1.06 1.11 1.29
BILO
0 1.01 1.23 0.49 1.24 1.24 0.66
12.5 1.01 1.04 0.60 1.24 1.24 0.66
25 1.06 1.03 0.64 1.24 1.16 1.02
50 1.24 1.28 0.72 1.47 1.52 0.76
100 0.92 1.19 0.85 0.87 1.36 1.10
BIPDT
12.5 1.01 0.97 0.86 1.16 0.99 1.08
25 1.16 1.00 1.20 1.35 1.14 1.34
50 1.09 1.37 0.96 1.24 1.52 1.11
100 0.99 0.98 0.97 1.07 0.90 1.07
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(a)
(b)
Fig. 4. Photomicrographs of stained cross-sections of the right iliac
artery at 200 magnification. The cholinergic nerves are stained
black-brownish. The scale bar represents 0.1 mm. (a) BI (0 weeks),
(b) BIPDT 50±100 J/cm dl (0 weeks).
Table 3. The mean amount of SMCs of the BI, BILO and
BIPDT groups at 0, 4 and 16 weeks (wk) with n 3 per group
per time-point.
Groups Amount SMCs
0 wk 4 wk 16 wk
BILO
0 173 189 348
12.5 177 220 357
25 169 194 350
50 185 200 318
100 133 169 290
BIPDT
12.5 123 163 233
25 97 180 281
50 7 33 241
100 3 25 196
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reduction of both MLD and MWD. Thus, restenosis
after angioplasty is determined by constrictive re-
modelling of the vascular wall and not just by the
occurrence of IH.39 This could explain why treatment
modalities that are only directed against the develop-
ment of IH are clinically unsuccessful. Presently, new
treatment modalities are under development to pre-
vent constrictive remodelling by inhibiting matrix
metallo-proteinases that are involved in remodelling
the subcellular matrix.40
The presence of cholinergic staining was semi-
quantitatively evaluated because we were mainly
interested is whether or not nerve damage occurred
after PDT. For evaluating the cholinergic function,
a quantitative analysis would have been required. As
the toxic effect of PDT occurs immediately and deple-
tion of acetylcholinesterase from a damaged nerve is a
fast process, the impact on vascular innervation was
studied on the first day after treatment. This study
shows that ALA-PDT inhibits IH as well as constrict-
ive vascular remodelling without innervation damage
of the tunica media. In fact, this treatment appeared to
decrease cholinergic staining of the tunica media and
increase the cholinergic innervation staining of the
tunica adventitia. As described by Furchgott, choliner-
gic innervation causes dilation in the presence of
endothelial cells in the tunica intima and constriction
of SMCs if achetylcholine is directly exposed to
smooth muscle cells in the tunica media.41 The
lack of response of SMCs in the tunica media to cho-
linergic stimulation may be due to SMC eradication
after BIPDT, which explains the absence of arterial
constriction. The underlying mechanism is not
completely elucidated, but warrants further study. A
direct cytotoxic effect resulting in permanent focal
acellularity of the area of the tunica media is oneof the mechanisms previously described with
external PDT.32,42
However, in this study only focal acellularity of the
tunica media in the BIPDT groups with 50 and
100 J/cm dl from 0 up to 4 weeks was found and the
tunica media was completely repopulated after
16 weeks. Grant and Nyamekye43,44 described acellu-
larity of the tunica media up to 6 months after external
illumination of damaged and undamaged ALA-
photosensitised arteries in a rat without giving any
explanation for this phenomenon. Additionally, ear-
lier reports described that in vitro innervation of the
tunica media stimulated hyperplasia,8 which may be
source for IH. This finding may also be relevant for
our observation of repopulation of the tunica media.
Another possible explanation is that in our study the
vascular wall was illuminated from the luminal side,
whereas most previous experimental studies used
external illumination.32,44,45 In that manner the ultra-
structure of the extracellular matrix may not be soEur J Vasc Endovasc Surg Vol 24, October 2002
330 E. E. E. Gabeler et al.severely and permanently altered by endovascular
PDT treatment and, therefore, the tunica media
could be repopulated. Notably, we found that light
alone at high fluence can prevent IH to some extent
as well, which was also described by others.46 Pre-
sumably, intracellular photosensitisers mediate this
selective cytotoxicity in the arterial wall.
How BIPDT led to the inhibition of constrictive
vascular remodelling is unknown. In a previous study
on PDT in the rat oesophagus we found that PDT-
dependent damage to the nerve plexus caused dila-
tion of the oesophagus.38 In this study no nervous
damage at the microscopic level could be observed,
but the function of the nerves in the tunica media was
not evaluated. This makes it less likely that permanent
constriction of the blood vessel is prevented by
switching off the nerves. Because innervation of the
tunica media most likely plays an important role in
the repopulation of the media and extracellular ultra-
structure organisation, the stimulatory effect of
BIPDT on the innervation of the tunica adventitia
may underlie the beneficial outcome of this treatment.
The problem of compensatory back-growth of IH and
constrictive remodelling with time will need further
studies, because, despite significant inhibition, slight
IH development was seen at 16 weeks in the experi-
mental groups.
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